THE World Health Organisation (WHO) has committed to supporting the government in implementing the safe use of long-acting injectable cabotegravir (CAB-LA), an injectable form of PrEP, in a move meant to further prevent the spread of HIV. This came after the Medicines Control Authority of Zimbabwe (MCAZ) recently approved the use of CAB-LA as pre-exposure…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions